Institutional investors purchased a net $9.1 million shares of GSK during the quarter ended June 2017 and now own 9.61% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FISHER ASSET MANAGEMENT LLC Bought 293.9 Thousand shares of GlaxoSmithKline
THE CLARK ESTATES, INC. Bought 265.0 Thousand shares of GlaxoSmithKline
CONFLUENCE INVESTMENT MANAGEMENT... Bought 105.1 Thousand shares of GlaxoSmithKline